Importance of Correlation between Gene Expression Levels: Application to the Type I Interferon Signature in Rheumatoid Arthritis

Background The analysis of gene expression data shows that many genes display similarity in their expression profiles suggesting some co-regulation. Here, we investigated the co-expression patterns in gene expression data and proposed a correlation-based research method to stratify individuals. Methodology/Principal Findings Using blood from rheumatoid arthritis (RA) patients, we investigated the gene expression profiles from whole blood using Affymetrix microarray technology. Co-expressed genes were analyzed by a biclustering method, followed by gene ontology analysis of the relevant biclusters. Taking the type I interferon (IFN) pathway as an example, a classification algorithm was developed from the 102 RA patients and extended to 10 systemic lupus erythematosus (SLE) patients and 100 healthy volunteers to further characterize individuals. We developed a correlation-based algorithm referred to as Classification Algorithm Based on a Biological Signature (CABS), an alternative to other approaches focused specifically on the expression levels. This algorithm applied to the expression of 35 IFN-related genes showed that the IFN signature presented a heterogeneous expression between RA, SLE and healthy controls which could reflect the level of global IFN signature activation. Moreover, the monitoring of the IFN-related genes during the anti-TNF treatment identified changes in type I IFN gene activity induced in RA patients. Conclusions In conclusion, we have proposed an original method to analyze genes sharing an expression pattern and a biological function showing that the activation levels of a biological signature could be characterized by its overall state of correlation.

[1]  Arlindo L. Oliveira,et al.  Biclustering algorithms for biological data analysis: a survey , 2004, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[2]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[3]  J. Pagano,et al.  Regulation of the Transcriptional Activity of the IRF7 Promoter by a Pathway Independent of Interferon Signaling* , 2005, Journal of Biological Chemistry.

[4]  Ron Shamir,et al.  EXPANDER – an integrative program suite for microarray data analysis , 2005, BMC Bioinformatics.

[5]  M. Peterson,et al.  Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[6]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Xiaodong Zhou,et al.  Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. , 2006, Rheumatology.

[8]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[9]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[10]  Carlos Prieto,et al.  Human Gene Coexpression Landscape: Confident Network Derived from Tissue Transcriptomic Profiles , 2008, PloS one.

[11]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[12]  G. Pinkus,et al.  Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis , 2005 .

[13]  Wentian Li,et al.  Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus , 2006, PLoS medicine.

[14]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Roded Sharan,et al.  Discovering statistically significant biclusters in gene expression data , 2002, ISMB.

[16]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[17]  Najia Shakoor,et al.  Drug-induced systemic lupus erythematosus associated with etanercept therapy , 2002, The Lancet.

[18]  B. Dijkmans,et al.  Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment , 2010, Arthritis research & therapy.

[19]  M Kathleen Kerr,et al.  Design considerations for efficient and effective microarray studies. , 2003, Biometrics.

[20]  V. Pascual,et al.  Cross-regulation of TNF and IFN-¿ in autoimmune diseases , 2005 .

[21]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[22]  Å. Lernmark,et al.  Interferon Expression in the Pancreases of Patients With Type I Diabetes , 1995, Diabetes.

[23]  L. Rönnblom,et al.  Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. , 2005, Arthritis and rheumatism.

[24]  Steven A Greenberg,et al.  Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. , 2005, Annals of neurology.

[25]  E. Pieterman,et al.  Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair , 2003, Genes and Immunity.

[26]  Richard M. Karp,et al.  Discovering local structure in gene expression data: the order-preserving submatrix problem , 2002, RECOMB '02.

[27]  T. Shirakawa,et al.  Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus , 2008, Lupus.

[28]  C. Auffray,et al.  Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis , 2010, Genes and Immunity.

[29]  C. Wijbrandts,et al.  Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients , 2007, Annals of the rheumatic diseases.

[30]  P. Gregersen,et al.  An Interferon Signature in the Peripheral Blood of Dermatomyositis Patients is Associated with Disease Activity , 2007, Molecular medicine.

[31]  C L Verweij,et al.  A subtype of multiple sclerosis defined by an activated immune defense program , 2006, Genes and Immunity.

[32]  George M. Church,et al.  Biclustering of Expression Data , 2000, ISMB.

[33]  J. Boeke,et al.  The incredible shrinking world of DNA microarrays. , 2008, Molecular bioSystems.

[34]  A. Syvänen,et al.  Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[35]  M. Peterson,et al.  Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus , 2004 .

[36]  D. Pisetsky.  Tumor necrosis factor α blockers and the induction of anti‐DNA autoantibodies , 2000 .

[37]  V. Pascual,et al.  Cross-regulation of TNF and IFN-alpha in autoimmune diseases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Ash A. Alizadeh,et al.  Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. , 2003, Arthritis and rheumatism.

[39]  Uwe Oelmueller,et al.  Stabilization of mRNA expression in whole blood samples. , 2002, Clinical chemistry.

[40]  S. Landolfo,et al.  Up‐regulation of the interferon‐inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells , 2005, Journal of leukocyte biology.

[41]  Tong Zhou,et al.  Extracting gene expression patterns and identifying co-expressed genes from microarray data reveals biologically responsive processes , 2007, BMC Bioinformatics.

[42]  D. Pisetsky.  Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies. , 2000, Arthritis and rheumatism.